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A
t the beginning of the year one would have never 
guessed that we would be navigating such 
interesting times as we are now. Like everyone 
else at the beginning of the year I went for my annual 
vacation with the family from 4 - 13 January. Actually, we 
ended up spending another day at the Holiday resort and 
only arrived back in South Africa on 14 January and I was 
back at work from 15 January. This annual retreat was full 
of fun and a lot of rest as I had worked throughout the 
Christmas and New Year’s season, much to the displeasure 
of my family. I also had a lot of time to re) ect and plan for 
the coming year and like most people we made New Year’s 
resolutions, I had resolved to eat better, spend more time 
with the family and to exercise more. 
So, once we got back home and settled, I decided to buy 
some vitamins for myself and the family. I reminded kids to 
eat at least 5 fruits or vegetables a day. As for myself I 
thought that eating 5 fruits or vegetables was not going to 
be feasible due to the nature of my work schedule, so I 
stocked up on good brand of vitamins and other supple-
ments to last me at least 6 months. On the exercise front I 
have always tried to walk wherever possible and my target 
has always been to go jogging at least 3 times a week. On 
average I would run for at least 30 minutes. So, my rhythm 
was set, and I was going to conquer 2020. 
From what I now know on 31 December 2019, the Wuhan 
Municipal Health Commission in China reported a cluster 
of cases of pneumonia in Wuhan, Hubei Province, and the 
COVID-19/Novel Coronavirus was eventually identi5 ed. 
The 5 rst recorded case outside China was on 13 January 
2020 in Thailand. On 22 January 2020 the World Health 
Organisation (“WHO”) issued a statement saying that 
there was evidence of human to human transmission in 
Wuhan but more investigation was needed to understand 
the full extent of transmission. By 30 January 2020 there 
were 7 818 total con5 rmed cases worldwide with the 
majority of these in China, and 82 cases reported in 18 
countries outside China. On 11 March 2020 the world 
concerned by the climbing levels of spread in severity and 
by the levels of inaction, the WHO made the assessment 
that CoVID-19 can be characterised as a pandemic. Back 
home on 23 March 2020 the President announced that 
South Africa would embark on a national lockdown starting 
on 26 March 2020. I vividly remember having a conversa-
tion with my wife and advising her to go shopping in 
preparation for the lockdown. She also works full time and 
when she 5 nally got time to go and do some shopping it 
was a nightmare because most of the shops in the Sandton 
area where empty. She came home on that day after going 
to multiple shops and purchasing only part of her grocery 
list. My birthday was on 25 March and Portia decided to 
spoil me on that day and took me for measurements for a 




bespoke suit. I reluctantly went in for the measurements 
because I was not sure when I would get to wear the suit 
and little did I know at that time that a COVID storm was 
about to hit. 
Being based in Sandton and coming into contact with 
people that travel frequently abroad for business and leisure 
I had a sense that this would become the Wuhan of South 
Africa. So, since beginning of March I was one of those 
people who had started wearing scrubs on a daily basis, not 
just for my procedures in the lab. I received lots of com-
pliments from my colleagues as they thought that I was 
making a fashion statement but in truth I took this approach 
because I had a premonition that this virus was closer than 
we knew and I felt I had to dress for war. 
I wouldn’t let my family come near me when I arrived home 
from hospital before going through my “decontamination” 
procedures. As a precaution I also started taking Chloro-
quine prophylaxis for the prevention of COVID-19 around 
the same time and even discussed an “Evacuation plan” 
with my wife in the event that either one of us or the chil-
dren fell ill and needed to rush to hospital.  
We all talk of Black Tax and part of my COVID-19 Black 
tax included buying Hand Sanitiser in bulk for distribution 
to my extended family. I managed to secure 500 litres of 
hand sanitiser on 23 March 2020. 
On 26 March 2020 I joined the Intensive Care Unit (“ICU”) 
Gauteng Corona Group which had been formed on 21 
March 2020 in Gauteng and has since spread nationally and 
regionally as a platform to share from local experience and 
guide clinical patient management. The 5 rst paper I obtained 
and read on that group was a 2007 article entitled “Severe 
acute respiratory syndrome coronavirus as an agent of 
emerging and re-emerging infection”, by Vincent C. Cheng, 
published in Clinical Microbiology Reviews Oct;2007:
660-694. The authors commented that the presence of 
a large reservoir of SARS-CoV-like viruses in horseshoe 
bats, together with a culture of eating exotic animals in 
Southern China, is a ticking time bomb.
At the beginning of the lockdown I recall that the drive to 
work during the 5 rst days of lockdown was surreal because 
the Gauteng roads were empty, it felt like Johannesburg in 
during Christmas. I literally used to pinch myself to make 
sure it was not a dream. I also recall that chloroquine was 
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the ) avour of the Month. I remember going frantically from 
pharmacy to pharmacy looking for whatever little stock of 
Chloroquine I could get. On the work front once the initial 
shock of being locked down began to wane we started 
having multiple planning meetings for COVID-19 from the 
beginning of April. I remember us discussing who was 
more at risk during one of those meetings, and I remember 
thinking to myself I am surely low risk since I am generally 
healthy and physically active. 
As part of our preparation for the coming ) u season my 
family went for ) u vaccination on 16 March 2020. I normally 
do not get the ) u vaccine. But this year with all the uncer-
tainties around COVID-19, I decided to get vaccinated. 
My 5 rst scare was on 30 March 2020 when I woke up with 
a running nose and slight fever. I was so paranoid that day 
that I decided to go and get tested for COVID-19, but the 
results came back negative. I also did the swab for respira-
tory viruses which came back positive for Rhinovirus. These 
symptoms settled within 2 days. I then had to retest for 
COVID-19 on 15 April 2020 as part of screening of all 
staff at the Mediclinic Morningside. This test was negative 
as well. 
However, on Monday 20 April I had a team meeting 
through which I felt restless. I struggled to focus, I could not 
properly articulate my items on the agenda and the meeting 
appeared to take longer than was necessary. I just thought 
it was fatigue as I had worked over the weekend. Even 
though the hospital had been closed for admissions, I had a 
few patients still admitted, some post-surgical. The following 
day at work was busy as well as I had a busy clinic. Later that 
night I felt a bit feverish and I woke up around midnight my 
wife checked my temperature and it was 38 degrees and 
my heart sank, I knew in that moment that this was it. 
Since the beginning of the lockdown I had been monitoring 
my temperature daily and it had never gone beyond 37 
degrees. I had a restless night and the following morning I 
got up early and immediately went to the drive through 
testing station. I got there before they had opened the 
testing station and nervously watched the staff set up. 
Impatiently I sat in my car while at the same time bracing 
myself for the uncomfortable test. I had a lot of thoughts 
racing through my mind wondering what I would do with 
my remaining patients in the wards at such short notice. 
Asking myself where I would quarantine since I was now 
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symptomatic and my wife and children were all con5 ned 
to the home. After what seemed like a lifetime the lady 
walked to my car and administered the test. This time I 
could not help it, I felt the tears welling up in my eyes as 
reality set in while she turned the swab a few times down 
my nose into the pharynx. After this I drove home and 
when I got into the house the kids were preparing to start 
their online sessions and they got so excited that I was 
back so early which broke my heart because my presence 
didn’t mean spending time together but rather time apart. 
My wife prepared a warm drink for me and got me settled 
into bed. She started asking me a lot of questions with 
worry etched on her face and most importantly she wanted 
to know why I wasn’t going to hospital and why I muttered 
that I did not want to be put on a ventilator etc? I explained 
to why I was not keen on being admitted into hospital, but 
assured her that I would be honest with her should I 
deteriorate signi5 cantly and urgently needed to go to the 
hospital and that she should be ready to execute our 
“Evacuation plan” as discussed. 
What she did not know was that since the hospital had 
been closed voluntarily for deep cleaning the previous 
week, we were not admitting general patients, but they 
had made a provision for staff members to be admitted as 
required. I was aware some of the people I had worked 
with in the ICU and High Care areas needed to be admitted 
for supplementary Oxygen therapy into the wards and the 
thought that this could be me weighed heavily on my mind. 
My wife quickly recognised that I wasn’t myself and even 
without the con5 rmation of the test results we proceeded 
as though I was positive and agreed that I would isolate at 
home. My wife moved out of our bedroom and made our 
room and study out of bounds. Our bedroom was ideal 
because it has a door that opens out to the garden so I 
could step out without interaction with the rest of the 
family and I could work in the study without running into 
the online scholars. In my mind I thought I was going to be 
able to sit and catch up on outstanding reports during the 
isolation period. I therefore arranged for my Personal 
Assistant to deliver some patient 5 les to the house. I still 
had about 10 patients in the hospital, so I made a few 
phone calls to hand them over and my colleagues were 
more than happy to assist. There was one patient who had 
presented with a Non ST Elevation Myocardial Infarction 
(Heart Attack) to Mediclinic Sandton with some respiratory 
symptoms who needed further treatment and I had been 
trying to refer her to another hospital group for care since 
we were not admitting patients to the catheterisation 
laboratory at Mediclinic Morningside. I received a positive 
COVID test result for that patient and the other Hospital 
Management upon hearing that decided it was risky for that 
patient to come across to them. As it turned out this 
speci5 c patient was also a healthcare worker and worked 
in one of the hospitals in Johannesburg and I had already 
received a few anxious calls from the family and colleagues 
as well. So, I had to counsel them telephonically and also 
explain the changes in management strategy as a result of 
the positive test result. Fortunately, the patient had 
responded to medical therapy initiated on presentation and 
was pain free. As a Cardiologist one always wants to know 
the anatomy as soon as possible in patients with Acute 
Myocardial infarctions. During all these telephonic inter-
actions I did not disclose that I was symptomatic and started 
my isolation, I had to wear the Doctor cap all the while 
dealing with my own internal turmoil. 
With all my patients handed over I 5 nally was in a position 
to start sorting myself out, then it dawned on me what I was 
up against. By late afternoon I was feeling fatigued and 
feverish and so I decided to start myself on Zithromax and 
continue on the Chloroquine. I had already taken a few 
paracetamols as I had a light headache which I thought was 
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more stress related than anything. Fortunately, a colleague 
had sent me script, but I could not get the Chloroquine 
dispensed from my hospital pharmacy because they needed 
a con5 rmed positive COVID-19 result which was not yet 
out. Fortunately, I still had some strategic stock of my own 
which I started using. From that night onwards my condition 
deteriorated quickly as I became more febrile and short of 
breath. Initially I thought it was just the anxiety of waiting for 
my results but objectively this was beyond anxiety. I lay 
awake that night and would check for my results every 30 
minutes. I literally did not know what to do with myself. 
Other symptoms that I also developed included hyper-
somnia, back pains, generalised joint pains and severe 
cough. Even when I changed position in bed, I would have 
severe coughing spasms which would take some time 
before settling. So I would focus my energy on trying to 5 nd 
a comfortable position and do my best to keep it. 
The shortness of breath rapidly worsened, I recall getting up 
at some stage to use the bathroom and almost falling from 
dizziness. I literally stayed up all night as I focused on making 
sure that I kept breathing. I found that if I prone the back 
pain was better and breathing improved, but it was not a 
comfortable position as I am not used to sleeping on my 
chest and stomach. The following morning, I was exhausted 
and I had little appetite and I struggled to keep down the 
small amounts of food I ate. I recalled the need to keep well 
hydrated and I would force myself to drink water slowly. I 
asked my wife to prepare plain vegetable soups which 
became my main source of nutrition for the following 2 
weeks. Because of the pain in the back and joints I took a 
lot of Paracetamol sometimes even 4 hourly. Eventually I 
would look back in shock when realised that I had taken 
almost 100 tablets in 10 days.
By day 4 I had also developed severe epigastric burning 
sensation which I attributed to Chloroquine and the Zithro-
max and so I decided to stop the Chloroquine. The fol-
lowing day I got a script of Prednisone and started taking 
40mg twice a day. That brought some relief to my breathing 
or lessened the intensity of my coughing spasms. With it I 
also started an oral anticoagulant and I took very high 
dosages on the 5 rst 2 days and then continued with normal 
doses daily which I have continued to date. I had heard of 
various steaming techniques and the 5 rst time I tried 
steaming I had such a bad coughing spasms such that I 
thought I was going to die. However, when I changed 
steaming with common Vicks I had a lot of relief in my chest 
and sinuses. I drained so much mucus it was shocking. I 
always observed the colour of the mucus. What really 
helped was combining steaming self-chest physiotherapy 
and postural drainage. This meant that I would spend a lot 
of time kneeling on the bathroom ) oor.
During the 5 rst week I spent most of the time lying in bed. 
Most of my time was spent in meditation and prayer as I 
had experienced multiple moments when I would run out 
of breath precipitously even whilst lying in bed and I would 
think that my moment of death had approached. A few 
times my wife walked into the room and would hear me 
breathing heavily and she would insist on taking me to 
hospital and I would beg her to allow me to settle down, 
saying that this was a passing phase. During those moments 
I would also refuse to have my saturations measured as I 
knew that they were very low and that it would cause her 
to worry. At some stage I had measured them alone and 
noticed that I had come down to 80% and so I would focus 
on breathing whenever I was having these episodes. One 
thing exacerbated these breathing paroxysms was cold air 
and so we made sure that the room was very warm and I 
also used a humidi5 er 24 hours a day.
When my wife would come in and clean my room, etc. I 
would sit in the garden, but I could barely walk without 
feeling like my chest in fact my whole body was on 5 re. 
Another worrying symptom which stayed with me is severe 
palpitations on exertion and I subsequently started myself 
on a beta blocker with great relief. An echocardiogram 
done 2 weeks later revealed that my heart was structurally 
and functionally normal. A Chest X-ray done then also 
showed bilateral in5 ltrates con5 rming a COVID pneumonia. 
On Thursday 30 April I managed to walk out of the house 
for the 5 rst time and I sat in the sun for 2 hours. On that 
day I recorded 1 119 steps. It was on the same day that I 
saw my 2 older children for the 5 rst time since the night of 
the 21 April. I remember my daughter coming to the 
window whilst inside the house and she blew me a kiss and 
that just broke me. I could not help the tears just welling up 
in my eyes as I waved back at her. Since 21 April I had the 
great fear of infecting my family and I would ask my wife to 
leave the bedroom soon after she brought me a beverage 
or a meal sometimes voicing my concern to her that the 
room was contaminated with the Coronavirus. 
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She developed a system which included setting aside crock-
ery, cutlery and trays exclusively for my use and she would 
leave meals in a tray by my bedside and steaming con-
coctions and some beverages in the bathroom. 
Since I battled to sleep during the night (if I’m being honest 
I was afraid to fall asleep as I thought I would die). I would 
sleep in the mornings and my days then venture out 
from some sunshine from about noon. From that initial 
venturing into the garden on 30 April I started going out 
every day and trying to do more walking. Those were 
precious moments for me where my 2 older kids would 
watch me and as I got stronger enough to walk down to the 
tennis court at the bottom of the garden they would follow, 
and we would have light conversations whilst keeping a safe 
distance. As I gained more strength they started joining me 
for walks and competing with me on who can go around 
the court the quickest. Those moments I spent with them 
reinforced the reasons I do what I do daily. Also, more and 
more I was spending time talking to family and friends on 
the phone. Initially I avoided video calling because the 5 rst 
comment was always how much weight I had lost, etc. I 
learnt to also avoid calls during times when I was out of 
breath especially when talking to elderly members of the 
family. I also spent a lot of time in prayer every night, would 
have communion and that was my sustenance. My faith 
kept me going, gave me the strength to look forward to 
another day. Also, the many people who called to just pray 
with me helped me deal with a lot of fears I had.
On 4 May I decided to go and have another COVID-19 test 
which came back positive. On that day I met some of the 
Emergency rooms staff in the parking lot where the testing 
was being done and they encouraged me to continue to 
5 ght this virus. When I received that positive result, I was 
disappointed, but I also knew that it could be due to the 
fact that I was shedding dead viruses and hence the posi-
tive result. My greatest supporter, my wife noticed my 
disappointment when I got the result the following day and 
tried her best to cheer me up. 
I also could sense that she was tired because she was 
looking after the children, supervising their home schooling, 
5 elding calls from concerned friends and family so when-
ever she would do checks on me I would tell her I was 5 ne 
and that she shouldn’t worry. 
I continued to grow stronger and on Friday 8 May and went 
again to retest for COVID-19 and it came back negative. At 
the time I knew that in-order to go back to work safely I 
needed to produce a negative test result. So I was so 
excited the Saturday morning when I got the negative result 
and started making plans to start going back to work. My 
wife was not keen on the idea of me going back but later 
agreed when I mentioned that I was going back to catch up 
on my reports. It was also important to me that I not be 
controlled by fear. So, Monday 11 May I have returned to 
work. It was also on that day that I made a Video which I 
posted on my YouTube channel which traumatised some 
people as I was still quite short of breath at the time. 
When I got to the hospital the walk from my car to my 
rooms was painfully long. I had to pace myself but it was 
good to be back in the belly of the beast even though for 
the 5 rst week I did not see patients. The masks made 
breathing a lot more dif5 cult since then I have learnt to 
pace myself with all activities. It has slowly been getting 
better as the weeks have gone by. The tachycardia or 
palpitations are better on the beta blockade. 
I have not yet resumed running because I had started doing 
some stretching and low impact exercises after 4 May and 
when I tested my muscle and cardiac enzymes they were 
signi5 cantly raised further motivating my taking of beta 
blockers and slowing my return to extreme exercise. 
One of the most important lessons I have learnt in this 
whole experience is to always value the relationships we 
have as human beings. With the love and support of my 
wife I would not have been able to go through this suc-
cessfully. Also the many friends and family who called or 
sent a message just to say you are in our thoughts and 
prayers. Also my Faith kept me going, I have never before 
had to dig this deep in prayer. I think Spirituality is an 
essential part of every person’s life. 
I used a lot of experimental medication at the time and 
medical interventions are important. However, there is a lot 
of value in loving relationships, good nutrition, good habits, 
i.e. prayer, exercise, no smoking, sobriety and work life 
balance when you can achieve it. This foundation and 
support system can only but help us when we face the 




ADDRESSING THE HIGH MATERNAL MORTALITY DUE TO 
CARDIOVASCULAR DISEASE IN SOUTH AFRICA
THE 5TH ANNUAL CAPE TOWN CARDIAC 
DISEASE IN PREGNANCY SYMPOSIUM 
Cardiac disease is an important contributor to maternal 
death in both lower-to-middle and higher-income countries. 
There has been a steady increase in the overall institutional 
maternal mortality due to cardiovascular disease in South 
Africa. The most important contributors are Peripartum 
Cardiomyopathy (PPCM), Rheumatic Heart Disease and 
unoperated congenital heart disease.
The annual Cape Town Cardiac Disease in Pregnancy 
Symposium is unique in that it draws participants from a 
broad spectrum of disciplines – obstetricians, gynaecolo-
gists, cardiologists, internal medicine specialists, anaesthetists 
and basic scientists. Our previous meetings have facilitated 
fruitful and engaging discussions which have led to new 
collaborations, research projects and publications. 
Recent advances in female heart disorders during maternity 
were the focus of the 5 rst “Cape Town Cardiac Disease in 
Pregnancy” symposium: from bench-to-bedside to popu-
lation studies held in 2015. The aim was to provide up-
to-date information on physiological changes in pregnancy, 
cardiac diseases in maternity, their pathological mecha-
nisms, current management and diagnosis and clinical 
research and therapies. The enthusiastic response received 
from both speakers and delegates led to this becoming an 
annual symposium and the 5th Cape Town Cardiovascular 
Disease in Pregnancy symposium will take place at the 
Hatter Institute, Chris Barnard Building, Faculty of Health 
Sciences, University of Cape Town, from Monday, 28  - 
Tuesday, 29 September 2020 (World Heart Day). This 
event provides an opportunity for leaders in the 5 eld of 
cardiovascular diseases in pregnancy to gather in Africa.
Professor Karen Sliwa, Director of the Hatter Institute for 
Cardiovascular Research in Africa, hosts these annual 
international events. The academic programme combines 
a broad spectrum of clinical and basic science topics, with 
an impressive line-up of cardiac and/or maternity specialists 
from around the globe, including South Africa, United 
Kingdom, Israel, Germany and France. Attendees include 
physicians, nurses, scientists and students. 
Just to highlight a few of the presentations - Professor 
Justiaan Swanevelder (Head of Anaesthesia, Groote Schuur 
Symposium participants 2019 show solidarity for a young woman who died due to PPCM. 
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Hospital, Cape Town) will give a talk on managing peri-
operative hypotension in pregnant women and the role of 
ECMO. 
Dr Ranio Zhang (Uganda Heart Institute) will present 
original and unpublished research data on cardiotoxicity of 
breast cancer medication in a female Uganda population.
A session chaired by Dr Blanche Cupido and Professor 
Mushi Matjila (Groote Schuur Hospital), will have 5 ve 
clinical scenarios of cardiac disease in pregnancy, presented 
by a range of speakers. 
Professor Karen Sliwa will present the results of more than 
700 patients enrolled in the European Cardiac Society 
EURObservational Registry on Peripartum Cardiomyo-
pathy showing some surprising data (Sliwa, et al. Eur Heart 
Journal 2020, in press). 
Professor Ntobeko Ntusi (Head, Department of Medicine, 
Groote Schuur Hospital and University of Cape Town) will 
review the variety of cardiovascular imaging modalities 
available for pregnant women to con5 rm the diagnosis, to 
assess disease severity and stratify risk, to prognosticate, 
and plan for appropriate management and to assess 
response to therapy. One feature is about safety counselling 
for women and the need to balance the goals of bene5 cence 
with avoidance of harm to mother and foetus.
The importance of climate change on cardiovascular 
pathology contributing to maternal death will be addressed 
by Professor Priya Soma-Pillay, who is a Member of the 
South African National Committee for Con5 dential Enquiry 
into Maternal Deaths (NCCEMD). 
The two-day symposium will be an exciting learning and 
networking opportunity and 10 clinical and 2 ethic CPD 
points will be provided (MDB001/013/09/2019).
Prof Karen Sliwa
Members often ask what value there is to belong to SA Heart®, the association representing their professional interest. “In hand 
material bene5 ts” are often hard to spell out, they would include e.g. the annual congress, the SA Heart® Journal with CPD 
opportunity and access to scholarships. However, intrinsic value of belonging to a group of peers, networking, getting advice 
and feeling supported is invaluable too. Leadership and committees work in the background and spend many hours to ensure 
you can concentrate on your practice and patient care. 
Our president, Dr Jankelow, also member of the private practice committee, spends many an hour mediating between members 
and medical funders. One of these members recently expressed his gratitude in a letter directed to Dr Jankelow:
I’m writing this note to personally express my heartfelt thanks for all your assistance with regards to my recent enquiries 
with one of the medical funders. As unpleasant as the enquiry was, I am most grateful for your personal time and effort that 
it took to get through this process. The continuous engagement with the medical fund concerned required an extraordinary 
amount of time and dedication, and not once did you complain nor become impatient with me. I’m not sure if you have 
anyone to assist you with these processes, considering how much time and effort they involve.
I certainly felt supported as an SA Heart® member, throughout this ordeal. I am almost sure that had it not been for the 
society’s full support, I may have found myself bullied into submission. Please pass on my thanks to the rest of the Private 
Practice committee for their assistance and to SA Heart® Board at large. Feel free to use this letter to remind everyone of 
the importance of this particular role that you, in particular and the private practice committee, in general, continue to do 
for those of us in private practice. It has certainly been comforting and helpful to have the society’s support. I trust that you 
will continue to provide the same support for any other colleague that may K nd themselves in this unfortunate situation.




r George Mukhari is an Academic Hospital situ-
ated in the North of Tshwane (Pretoria). It serves 
as a teaching hospital for the Sefako Makgatho 
Health Sciences University formerly known as the Medical 
University of Southern Africa. It mainly serves the people of 
Northern Tshwane and receives referral from some parts 
of North West and Limpopo Provinces. The paediatric 
outpatient clinic sees over 10 000 patients annually and 
10% of those are cardiac patients. The department of Pae-
diatrics and Child Health functioned for a long time with 
general paediatricians with special interest in different 
subspecialities, the only two subspecialised wards were 
oncology and neonatology. There has been signi5 cant 
growth and development in the department with the 
divisions of paediatric cardiology, nephrology and oncology 
having been recognised and accredited for training by the 
HPCSA and all headed by women.   
I was born in Soweto from a staunch Catholic family, and 
the 9th child from a family of 11 children. My late parents 
loved the phrase " Ora et labora" which means pray and 
work in Latin, and that has really worked for me. My 
husband and I have also adopted the phrase for our 3 
beautiful children. I completed my undergraduate degree at 
Medunsa in 1995, obtained Fellowship in Paediatrics with 
the College of Medicine of South Africa in 2002 and started 
working as a general paediatrician in 2003 at Dr George 
Mukhari Academic Hospital, then Ga-Rankuwa Hospital. I 
have always had an interest in paediatric cardiology and 
wanted to improve the outcomes of children born with 
congenital heart diseases. Since then I was responsible for 
the paediatric cardiology patients together with my col-
league Dr Nkohane, who also has great interest in paediatric 
cardiology, and gained quite a lot of experience in doing 
echocardiograms and cardiac catheterisations from the pre-
vious paediatric cardiologist.
It was a challenge to offer proper care to cardiac patients 
because we were not trained in the 5 eld. Therefore, most 
of our patients had to be referred to Steve Biko Academic 
Hospital for further management, and that was really 
frustrating. It was also a great disadvantage to both under-
graduate and post graduate students in paediatrics as they 
only had exposure to simple cardiac lesions that we could 
manage onsite. It was through the help of Prof Takawira, 
who is the head of Paediatric Cardiology division at Steve 
Biko Academic Hospital and Prof Mawela the current 
head of the Paediatric and Child Health Department at 
Dr George Mukhari Academic Hospital and Sefako 
Makgatho Health Sciences University that I joined the 
paediatric cardiology unit at Steve Biko Academic Hospital 
in 2014. The whole cardiology team at Steve Biko Aca-
demic Hospital was very supportive throughout my training 
and I successfully completed my Fellowship in Paediatric 
Cardiology in 2016.
I went back to Dr George Mukhari Academic Hospital in 
2017 and had to deal with the challenge of trying to set up 
a paediatric cardiology unit in a department that was not 
prepared for subspecialists. 
Some of the challenges faced were:
 ■  motivating for a dedicated cardiac cubicle for better 
management of cardiac patients;
 ■  motivating for appropriate equipment in the clinic, 
wards and the cardiac catheterisation theatre; and
 ■  dealing with the expectation to look after all general 
patients and only focus on “your speciality” afterwards. 
We often left the hospital after 6, sharing general paediatric 
calls equally with colleagues while being on call for paediatric 
cardiology daily. We managed to succeed with some of the 
challenges. The paediatric cardiology clinic sees about 25 
patients per week and we have about 10 cardiac admissions 
per week. We also have one theatre day per week and 
perform cardiac catheterisations on 2 patients per week, 
mainly diagnostic catheterisations. We did our 5 rst per-
cutaneous Patent Ductus Arteriosus (PDA) closure and 
balloon dilatation of the pulmonary valve on the 20 April 
2017 and we are grateful to Prof Takawira for his support 
as we were taking baby steps. We initially started with 
simple procedures with the aim to progress to complex 
interventions when the whole team had gained experience 
and con5 dence. This has really made a signi5 cant difference 
to patients that had to be on the long surgical waiting list 
and has led to reduced hospital stays. We are gaining 
con5 dence and experience daily and plan to do all complex 
cardiac interventions onsite in the near future. Currently I 
attend to these patients with colleagues at Steve Biko. 
The challenges we are facing are staff shortages, on both 
the medical and support staff. Being the only paediatric 
cardiologist in the hospital basically means being on call 
every day for the whole year. It also means that the major-
ity of time is spent on patient care and teaching and very 
little time, if any on research, which is not good for an 
academic institution. There is also a lack of an experienced 
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nursing team in the cardiac catheterisation theatre. We 
only have one experienced nurse who works with monthly 
rotational nurses, which does not give them adequate 
exposure to gain experience and con5 dence. This poses a 
great challenge when faced with complex cardiac lesions 
and complex cardiac interventions. The whole team should 
always be ready to act promptly and effectively when doing 
procedures in the catheterisation theatre to prevent and 
to react to complications that may occur. We have a long 
waiting surgical list for the complex congenital heart lesions. 
Lack of cardiothoracic surgeons with interest in congenital 
heart lesions is our other challenge, our onsite cardiothoracic 
surgeons are mainly operating on the simple congenital 
heart lesions and we have to refer our complex cases to 
Steve Biko Academic Hospital. There is only one surgeon 
there and he will be retiring at the end of this year. This is 
also a challenge because our ICU and theatre nursing staff, 
cardiothoracic registrars and the paediatric cardiology fel-
low are not getting adequate exposure to intra operative 
and post-operative management of these patients.   
The Paediatric Cardiology unit at Dr George Mukhari 
Academic Hospital and Sefako Makgatho Health Sciences 
University is growing with the support from the head of our 
department and the paediatric cardiology team at Steve 
Biko Academic Hospital. We received accreditation and 
recognition for training by the HPCSA in 2018 and we 
started with training of our 5 rst fellow in July 2019. We plan 
to train more fellows and expand our paediatric cardiology 
unit and services to make a signi5 cant contribution to the 
outcomes of children born with congenital heart problems. 
Dr Mamokgethi Moshe, Paediatric Cardiologist
Department of Paediatric Cardiology
Dr George Mukhari Academic Hospital
Dr Mamokgethi Moshe, Paediatric 
Cardiologist.
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t is amazing how we as health care professionals have 
adapted to the changes the COVID-19 pandemic has 
brought before us, and it is with great pride that I count 
myself among the thousands who are ready to assist at the 
frontlines. 
I would like to express my thanks to my Executive 
Committee Members for their continued and unwavering 
dedication to furthering heart failure, even during this pan-
demic. The Exco are Martin Mpe (President), Jens Hitzeroth 
(Vice-President), Eric Klug (Ex-Of5 cio President), Darryl 
Smith (Treasurer) and Nash Ranjith (Secretary), as well as 
Karen Sliwa, Tony Lachman, Makoali Makotoko, Nqoba 
Tsabedze, Ntobeko Ntusi and Mpiko Ntsekhe. 
HEFSSA HEART FAILURE GUIDELINES
We are excited to announce that the HeFSSA Chronic 
Heart Failure Guidelines 2020 (based on the ESC HF 
2016 guidelines, with substantial Africanisation) has been 
accepted by the SAMJ and will be published and available 
by mid-August 2020. Thank you to Dr Jens Hitzeroth who 
led the review, with substantial contributions from the 
HeFSSA Executive (as clinical and research experts). This 
publication includes an update of the Chronic Heart 
Failure Algorithm and will be made available on the 
HeFSSA website.
HEART FAILURE SPECIALIST WEBINAR 
On Thursday, 2 July, HeFSSA hosted a Heart Failure 
Specialist Webinar speci5 cally for cardiologists and specialist 
physicians. Dr Nqoba Tsabedze focused on an update 
overview of SARS-COV2 and the viral pathology and links 
to heart failure, and Prof Mpiko Ntsekhe spoke from 
personal experience on the Western Cape as the epicenter 
of the South African pandemic at the beginning of July. This 
webinar was sponsored by Pharma Dynamics and well 
attended by 250 delegates. 
HEFSSA NON-CARDIOLOGIST 
WEBINAR SERIES 
The HeFSSA Non-Cardiologist Webinar Series focuses on 
Contemporary Heart Failure Management, and speci5 cally 
targets the General Practitioner, Specialist Physician and 
Allied non-prescriber HCP. Topics and faculty include:
Webinar “Tele-Cardiology and Lifestyle ModiK cations 
for the Heart Failure Patient” (11 July)
Dr Tony Lachman presented on the Role of Tele-Cardi-
ology and the impact of the COVID-19 Pandemic on the 
Heart Failure Patient. Dr Sandra Pretorius spoke on 
nutrition and advising heart failure patients on immune-
boosting and heart healthy food choices. This event was 
well attended by more than 400 delegates, not only from 
across South Africa, but also continental. 
Webinar “A Review of the Heart Failure Guidelines 
2020” (1 August)
Dr Jens Hitzeroth will give an in-depth review of the 
upcoming guidelines publication in the SAMJ, with Prof 
Ntobeko Ntusi, Dr Blanche Cupido and Dr Charles 
Kyriakakis as panelists. We have 1200 RSVPs at the time of 
writing and expect at least 700+ delegates to dial in. 
The next 2 Non-Cardiology webinars are planned for: 
 ■  22 August on COVID-19 and Heart Failure, with Prof 
Naresh Ranjith.
 ■  12 September dealing with Diabetes and Heart Failure, 
with Prof Eric Klug as the lead. 
A recording of the above webinars will be made available 
on the HeFSSA website for those delegates who are not 
able to attend on the day (please allow 10 days following 
the meeting for posting). 
We are privileged to acknowledge our corporate supporters 
for the unconditional grants which allow us to offer these 
events free of charge, namely: AstraZeneca, Boehringer 
Ingelheim, Cipla, P5 zer, Pharma Dynamics, Novartis, Novo 
Nordisk, Servier and Vertice Medtech. 
Several other projects are still in planning such as Cardio 
Update for Non-Cardiologists and HF Snapshot Survey 
(research).
Dr Martin Mpe
HEART FAILURE SOCIETY OF SOUTH AFRICA
We are ready 
to assist at the 
frontlines.
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INCORPORATING MULTIMODALITY IMAGING IN TRAINING 
IN THE SOUTH AFRICAN CONTEXT
INTRODUCTION
In daily clinical practice, cardiovascular (CV) imaging has 
experienced major strides and advances in relation to 
cardiac imaging procedures of echocardiography, nuclear 
cardiology and lately cardiac computed tomography (CT) 
and magnetic resonance imaging (MRI).(1,2) Therefore, it is 
perhaps time to revise the training standard for fellows 
interested in CV imaging.
OLD AND THE NEW
Many quali5 ed Cardiologists are seeking training expe-
riences through courses and conferences to acquire new 
skills in cardiac CT and MRI because such technologies did 
not exist during their training period.(1,2) Due to a de5 ciency 
of cardiologists it is no longer suf5 cient to have general 
cardiologists possessing expertise in only 1 or 2 of the 4 
imaging modalities. It surely would be advantageous if 
newly quali5 ed cardiology fellows entering the 5 eld could 
provide expert supervision and interpretation in various 
cardiac imaging techniques.
CURRENT STATUS REGARDING CARDIAC 
IMAGING IN SOUTH AFRICA
 ■  Training at most institutions limited to Echocardiography 
during the 3-year Fellowship.
 ■   Echocardiography is the domain of the Cardiologist. 
Radiologist not trained formally in this imaging modality.
 ■  Cardiac CT, MRI mostly done at private institutions by 
Radiologists/Radiographers. 
 ■  Recently there has been an emergence of cardiac MRI 
service in 4 major academic public institutions. 
 ■  Nuclear Medicine available at major academic public 
and private institutions.
 ■   No institution offers formal Fellowship training in multi-
modality cardiac imaging.
PROPOSED STRATEGY FOR DEVELOPING 
A MULTIMODALITY CARDIAC IMAGING 
CENTRE(S) IN THE SOUTH AFRICAN 
CONTEXT
 ■  Multi-disciplinary approach is vital. Use of existing local 
resources and expertise.
 ■  Non-invasive Cardiologist, Radiologist, Nuclear Physi-
cist, Electrophysiologists and interventional Cardiologist 
need to collaborate.
 ■  Compulsory rotation of Fellows training in Cardiology, 
Nuclear Medicine and Radiology fellows to each of the 
abovementioned disciplines with the aim of acquiring at 
least level 1 competency.(1,2)
 ■  Currently in South Africa Imagers are functioning in 
Silos and this is detrimental to all and above all to 
patient care.
 ■  Establishment of cardiac Imaging centres of excellence 
that is all inclusive to those training in the 5 eld of 
Cardiac Imaging and want to function independently as 
a cardiac imager.
ROLE OF CARDIAC IMAGING SOCIETIES
 ■  The role of the cardiovascular imaging societies should 
remain strong and relevant if this new advanced multi-
modality imaging discipline is to succeed.(1,2)
 ■   The societies must continue to be campaigners for 
research and development of cardiovascular imaging 
modalities. 
 ■   They should continue with a strong attention on edu-
cation in the form of continuous medical education 
offerings, publications, annual conferences, and provision 
of educational resources and mentors. 
It is perhaps 
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 ■   Examinations in their speci5 c 5 elds to assess know-
ledge and interpretive skills and evaluate competency 
should be offered to ensure a high standard of reporting 
and safety.
CONCLUSION
The future of cardiac imaging in South Africa is a multi-
disciplinary integration of all imaging modalities. This will 
facilitate better training and enhance patient care. My vision 
is a dedicated multimodality cardiac imaging centre in South 
Africa equipped with imaging experts, researchers and 
equipment that offers advanced training and certi5 cation in 
a cost-effective manner to all interested in cardiac imaging. 
Below are examples of 2 patients (Figure 1 and 2) that 
underwent multimodality imaging at Chris Hani Baragwanath 
Academic Hospital. 
REFERENCES
1.   Beller GA. A proposal for an advanced cardiovascular 
imaging training track. Journal of the American College of 
Cardiology. 2006;48(7):1299-303.
2.   Narula J, Chandrashekhar YS, Dilsizian V, Garcia MJ, 
Kramer CM, Malik S, Ryan T, Sen S, Wu JC. COCATS 4 
Task Force 4: Training in multimodality imaging. Journal 
of the American College of Cardiology. 2015;65(17):
1778-85.
Dr Ruchika Meel
Consultant and Post-doctoral Carnegie Fellow, 
Cardiology, Chris Hani Baragwanath Academic 
Hospital and University of the Witwatersrand
INCORPORATING MULTIMODALITY IMAGING continued
FIGURE 1: Multimodality imaging of a patient with giant circumN ex artery aneurysm (arrows) with 
Trans-oesophageal echocardiography (far left, top and bottom) showing beaded appearance on cross-
section with continuous N ow and cardiac computed Tomography (middle top and bottom panels and far 
right top and bottom panels) delineating the origin and drainage of the aneurysm through a P stula into 
the coronary sinus.
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FIGURE 2: A case of systemic sclerosis complicated by an aneurysm and patchy P brosis of the heart 
imaged with 2 dimensional echocardiography (top left and middle panel), strain imaging (top right 




habo Gregory Ngaka, a 26-year-old young man 
from Mount Fletcher, a small town in the Eastern 
Cape, South Africa. I am a Chief Cardiac Tech-
nologist based at the Nelson Mandela Academic Hospital 
(NMAH) in Umtata. My career journey started in 2012 
when I left for Durban to study Clinical Technology at the 
Durban University of Technology. In all honesty, I didn’t 
have much of a clue about the course except for the fact 
that there was an option to specialise in the heart. Given 
how attentive I used to be in high school during Life 
Sciences (Biology) when we were learning speci5 cally about 
the cardiovascular system, I thought it was worth a try. I 
beat Murphy at his own game because – well, here I am!
I completed my in-service training at Groote Schuur 
Hospital (GSH) in Cape Town, Western Cape, where I saw 
myself grow remarkably both academically and personally. 
As I progressed, I discovered that I had the love for sharing 
knowledge. With GSH being an academic hospital, I had 
the opportunity to teach and train student Cardiac Tech-
nologists, which turned out to be very productive. 
As I grew in the 5 eld, I developed an interest in Pacing 
and Electrophysiology (EP) because I had always found it 
interesting to observe – even though I hadn’t had the 
slightest idea of what was happening - the 3D mapping of 
the heart on the CARTO Mapping System. The 2 EP-
specialised Technologists, Human Nieuwenhuis and Marclyn 
Govender, together with Prof Ashley Chin (Electrophysi-
ologist at GSH), played a huge role in my growth in EP and 
Pacing. I later identi5 ed a gap in knowledge in this 5 eld 
amongst other Technologists, which prompted me to start 
a WhatsApp Group through which I share Zoom-recorded 
videos of myself presenting educational content on this 
subject. I found that through teaching, I get to advance in 
knowledge and retain information better, while someone 
else also bene5 ts from the knowledge – it’s a win-win.
When a new Cath Lab was established at NMAH, I 
identi5 ed an opportunity to become a part of a team that 
will render cardiac services that have never been rendered 
there before. I had already been equipped with the neces-
sary skills, and I felt that I was ready to apply them on home 
ground. That was when I decided to leave Cape Town for 
Mthatha to begin my new journey.
CATH LAB (MTHATHA)
Since the opening of the Lab in June 2019, we managed to 
do a total of 132 cases, most of which were referrals from 
East London (EL) and Port Elizabeth (PE). This includes 
both adult and paediatric patients. Before I came to Mthatha, 
I had never had the opportunity to be a part of a paediatric 
case, be it an intervention or diagnostic study. The 5 rst 2 
weeks were a little troubling for me because everything I 
knew regarding paediatrics was theoretical. However, after 
the 5 rst 2 weeks, I was more con5 dent with the cases as I 
better understood the study protocols and the pathologies. 
I always say that one truly knows something when both 
theory and practical are married. The team managed to do 
43 paediatric cases, with just over a quarter of them being 
PDA closures. These interventions were mind-blowing for 
me, especially with a diligent Paediatric Cardiologist like 
Dr Zongezile Makrexeni. I have learnt a lot from him. The 
rest of the patients were adults. The acute coronary syn-
dromes (ACS) were mostly referrals from EL and PE, 
while cardiomyopathies and valvular heart disease patients 
came from local regions. We managed to do close to 30 
coronary interventions with Dr Khulile Moeketsi, whose 
calm demeanour and openness to opinion during cases 
ticks some boxes in the team. The rest of the cases were 
diagnostics, Pericardiocentesis (for the IMPI Trial) and 
prosthetic valve screening.        
BIOGRAPHY - THABO GREGORY NGAKA
Thabo Gregory Ngaka, Cardiac Technologist
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ECHOCARDIOGRAPHY
I had already anticipated that I would be doing many 
Echocardiograms because of the very prevalent rheumatic 
heart disease (RHD) in the Eastern Cape. About 240 
transthoracic echocardiograms were performed from 
June 2019, majority of which were from the Cardiac Clinic 
and those that were being worked up for referral to 
Inkosi Albert Luthuli Hospital (IALH) in Durban, KwaZulu-
Natal (KZN), for Cardiac surgery. The clinic is primarily 
referred to as the Super-Specialist Clinic as it is shared 
amongst Cardiology, Rheumatology, Endocrine and Gastro-
Intestinal clinics.
PACING 
One of the concerns I had was whether I’d get a chance 
to do some pacing work since this is my favourite area 
of Cardiology. Fortunately, there were some cases that 
required permanent pacing. So far, we have implanted 11 
VVI pacemakers, 1 primary ICD, and 1 ICD generator 
replacement. Because of budget constraints, we prioritise 
primary device implants. However, we had to do the ICD 
generator replacement as it had already reached its recom-
mended replacement time. 
TEACHING AND THE FUTURE 
Cardiology is a new department at NMAH, which means 
that there are a lot of new concepts and protocols that 
need to be taught to nursing staff and doctors. I have per-
sonally done some training lessons with nurses in the wards 
and the ICU. Our Cardiologists, Nurses and Radiographers 
are also playing their part in training and education. There 
have been requests to assist registrars and medical of5 cers 
with ECGs and Echocardiography, which I assist with where 
I can. I do this through a WhatsApp group as well. How-
ever, with Echocardiography, I usually encourage identifying 
patients in the wards and then having a bed-side scan and 
discussion. I 5 nd that this is the most effective way because 
the more you do something, the better you become. 
I am looking forward to many more lessons because I also 
get to learn a lot from the doctors clinically. For as long as 
we maintain that relationship, this will be a very productive 
journey. 
My long-term goal, however, is to be more specialised in 
Pacing and Electrophysiology. I want to become a Certi5 ed 
Electrophysiology Specialist (CEPS) and a Certi5 ed Cardiac 
Device Specialist (CCDS). I want to be able to continue 
sharing my EP and Pacing expertise with fellow Technolo-
gists. Until then, I shall continue doing what I do as best as 
I can, with the hope that the Universe will smile upon me.
Back row (left to right): Sr T.T. Mazingela, 
Dr T.O. Fathuse, Sr. S. Mntonintshi and
Mr T.G. Ngaka.
Front row: (left to right): Sr N. Mananga, 
Dr K.M. Moeketsi, Sr N. Masiza and
Mr C. Siyongwana
Left to right: Sr N. Masiza, Dr Z.M. Makrexeni, 
Sr T.T. Mazingela and Dr L. Ralarala.




n 2018, SA Heart® together with Discovery launched the 
SA Heart® Emerging Leaders Award. This award was 
aimed at clinicians - in the 5 eld of cardiology (adult or 
paediatric) or cardiovascular practice - under the age of 40 
or within 3 years of qualifying. The aim was to identify 
leaders in their 5 eld, based on previous achievements, 
current projects and their vision for cardiovascular care in 
South Africa. 
The 8 5 nalists elected were: 
 ■  Dr Khulile Moeketsi
 ■  Dr Blanche Cupido
 ■  Dr Alfonso Pecoraro
 ■  Dr Ruchika Meel 
 ■  Dr Tim Pennel
 ■  Dr Mamaila Lebea
 ■  Dr Annari Van Rensburg 
 ■  Dr Don Zachariah
The award was presented to Dr Khulile Moeketsi at the 
SA Heart® Congress in Sun City in 2018. This entailed not 
only a monetary stipend but also opportunities in leadership 
training as well as mentorship by leadership of SA Heart®.
At the SA Heart® Congress in 2019, there was an oppor-
tunity for these emerging leaders to showcase the work 
they were involved in as well as their future visions. 
Regrettably this session (The CVD Imbizo) followed on 
immediately after our amazing World Cup win over England 
and attendance at the session was therefore dismal.
This however did not detract from the amazing work 
presented at that forum. Though admittedly on a high from 
the rugby win, I left the session even more elated at the 
prospect of our organisation and our profession being 
home to such amazing talent and drive. 
The session was chaired by Dr Khulile Moeketsi and Dr 
Mamaila Lebea. Dr Moeketsi presented by the vision for his 
newly established cardiology unit in Umtata and a fruitful 
discussion delineating the problems and some suggestions 
for solutions ensued. 
Dr Tim Pennel and I spoke of the scourge of heart failure in 
South Africa, the poor outcomes and the fact that simple 
measures to streamline referral practices and clear path-
ways can open up earlier life-saving therapies for South 
Africans. A long discussion on how to expand transplanta-
tion and allow access for other provinces took up quite a 
lot of time, and though immediate solutions to such a 
complex problem is not imminent, hearing the diverse 
opinions was enlightening to help form future solutions. 
Alfonso Pecoraro showcase the basic cardiac ultrasound 
training programme for community nurses that has proven 
successful in their secondary level facilities, and we all learnt 
many tips on how such a programme can be duplicated in 
our own settings.
Dr Ruchika Meel spoke of the need of an integrated well-
rounded imaging training programme for Cardiologists as a 
potential non-interventional cardiology track. Her power 
and passion on this topic was striking and very uplifting and 
SA HEART® EMERGING LEADERS PROGRAMME – 
BUILDING A PIPELINE 
Poor attendance at the session.
Dr Tim Pennel and Dr Alfonso Pecoraro.
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very much needed in an area of Cardiology that has thus far 
been relatively neglected in the mainstream. 
The session ended with Don Zachariah providing an 
overview of how public and private partnerships have 
uplifted and promoted community cardiology care and pro-
vided a model that one certainly hopes can be duplicated 
across our country.
As the incoming president elect of SA Heart®, I was 
particularly encouraged. This is who we are – innovative, 
driven and eager to overcome adversity. It really makes my 
heart glad to see the passion of our clinicians for our people 
and I look forward to building with all of you in future….
Blanche Cupido
Proudly South African.
PASSING OF PROF LUNGILE PEPETA ON 7 AUGUST 2020
With great sadness we mourn the loss of our colleague and friend, Professor Lungile Pepeta – Paediatric Cardiologist, former 
Vice-President of SA Heart® and Dean of Nelson Mandela Faculty of Health Sciences. 
A gentle giant, a dedicated and paediatrician, and a wonderful family man. He loved his profession and his country. He will be 
sorely missed in our community.
We promise to take up the baton you have left behind for us to pick up, in your passionate quest to uplift and improve the 
health of our commmunities, with the resolve to never fail you. 
Lala ngoxolo tata Pepeta. Sithi ngxe kusapho nakwiisizwe siphela.
PASSING OF PROF SOLLY LEVIN ON 9 AUGUST 2020
It is with great sadness that we learn that Prof Solly Levin has passed away on Sunday afternoon. We wish his immediate and 
extended family comfort and peace during this time of mourning. A giant of a man who loved teaching and whose knowledge 
knew no bounds. All paediatric cardiologists in South Africa and beyond our borders are indebted to him for his contribution 
to the subspeciality.
Prof Solly Levin, Paediatric cardiologist and honorary SA Heart® member died after a short illness and following the death of 
his wife just days ago. He will be deeply mourned. 





he Lipid and Atherosclerosis Society of Southern 
Africa (LASSA) is interested in all matters related 
to lipid and lipoprotein metabolism, including the 
common problems of dyslipidaemia relating to atheroscle-
rosis and now known to be eminently preventable by life-
style and in many instances, medication. Hypertriglyc-
eridemia linked to atherosclerosis and pancreatitis is also 
common. The lipidologist, though able to deal with the 
whole spectrum of problems, focuses on the most severe 
of the common problems and deals with several other 
metabolic disorders. LASSA aims to provide the expertise 
in service, teaching and research in Lipidology despite its 
small membership and limited resources. 
The past few decades in South Africa saw an emphasis on 
infectious disease: tuberculosis (TB) and human immuno-
de5 ciency virus (HIV) infections. Control of the HIV infec-
tion by medication improved the prognosis but now 
leaves people at high risk for cardiovascular disease. The 
recent acute infectious epidemic of COVID-19 affected 
older people and those with diabetes and underlying heart 
disease very severely as well. 
This newsletter comes as the COVID-19 epidemic in South 
Africa is hopefully receding. What are the 2 most important 
issues for LASSA to consider when we return to normality 
after the epidemic? Firstly, to provide expertise in the 
relatively new discipline of Lipidology not only to serve 
those with people and patients at risk but also to teach and 
perform research. Secondly, to educate the medical pro-
fession and public about familial hypercholesterolemia (FH) 
not only because this is a particular problem in South Africa, 
but also because there is an international move to ensure 
that this common disorder is recognised and dealt with. 
THE PROMOTION OF LIPIDOLOGY 
Cardiovascular disease resulting from atherosclerosis mani-
fests in heart attacks, angina, heart failure, strokes, impaired 
circulation to the legs and gangrene. Such diseases are 
common causes of suffering and premature death in 
developed countries and were predicted to exceed infec-
tious disease in developing countries by 2020.(1)
Over the past 2 - 3 decades moderate dyslipidaemias, 
encompassing blood cholesterol concentrations between 
5 and 7mmol/L, triglycerides between 1.7 and 5mmol/L, 
higher-than-ideal LDL cholesterol and lower-than-ideal 
HDL cholesterol, have been researched intensely. These 
are the typical setting in which most people with atheroscle-
rosis are found. Especially the statins have proved safe and 
effective treatment. The South African Guidelines for dys-
lipidaemia,(2) brought out jointly by LASSA and the South 
African Heart Association (SAHA), guide the medical prac-
titioner to assess the risk of patients by a calculation 
according to which lifestyle and medication are prescribed 
similar to overseas guidelines. This caters for the majority of 
cases of dyslipidaemia but the calculation is invalid in severe 
dyslipidaemias. There is, unfortunately, limited expertise for 
more severe dyslipidaemias and management is often not 
optimised for these patients. 
Such severe or uncommon problems should be evaluated 
by lipidologist or at least by specialists with more training or 
experience. Owing to the withdrawal of support for special 
clinics and dedicated laboratories at teaching hospitals, 
there is concern about the training in Lipidology received by 
specialists in internal medicine, paediatrics, cardiology and 
endocrinology. Lipidology courses were planned to alleviate 
this problem. Prof Dirk Blom (Western Cape) and Prof 
Derick Raal (Gauteng) made important contributions to 
international studies in the treatment of FH. They parti-
cipated in the LASSA Lipidology courses. In 2018 a 3-day 
teaching course was arranged in Cape Town, chie) y for 
members of the Netherlands Lipid Association. In 2019 
another course was held in Cape Town for senior registrars 
and other medical practitioners. The steps taken to combat 
the COVID-19 epidemic in South Africa resulted in the 
cancellation of 2 intended courses on Lipidology for 2020. 
LASSA will endeavour to resume these as soon as the 
epidemic recedes. 
The need to develop Lipidology was emphasised in the 
document submitted by LASSA to the Department of 
Health at the end of last year when input was requested 
concerning non-communicable diseases. Only the teaching 
hospital clinics in Cape Town and Johannesburg offer expert 
consultations to the public and private sector. The research 
laboratory in Cape Town is currently the only means of 
doing more specialised testing in Lipidology. All of these 
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services can be approached for assistance. The most expe-
dient way of providing consultation and diagnosis for severe 
disorders such as FH might be to create dedicated facilities 
within a National Health Insurance scheme so that the 
public and private sector patients can receive best care. 
Relevant teaching and training can ) ow from this until the 
training of specialists improves.
2020 IS FOR RENEWED INTEREST IN FH 
WORLD-WIDE
FH is not rare. Somehow, despite recent advances in its 
diagnosis and big advances in its treatment, FH has not 
received due attention world-wide. South Africa is 
renowned for founder effects of FH. Prof David Marais 
and Prof Derick Raal are involved in the networks created 
within the European Atherosclerosis Society FH Study 
Collaboration. The FH Foundation is a lay organisation 
dedicated to the cause of FH in the USA. Their “call to 
action” was published in January 2020.(3) Prof David Marais 
participated in the awareness programme about FH by 
the FH Foundation. 
So, 5 rstly, what is FH and when and in whom should this 
diagnosis be suspected? (2) Is there effective treatment? 
(3) What do we know about FH in South Africa? (4) How 
can we improve care for FH in South Africa? 
FH is an inherited condition in which the removal by the 
liver of LDL, the particle that carries most of the blood 
cholesterol, is impaired as a result of a fault in the LDL 
receptor (LDLR) activity from errors in the gene. Con-
sequently, the LDL concentration is elevated in every 
affected person from birth. The same problem can arise 
when apoB100, the protein on LDL that should bind to the 
LDLR, does not work. Rarely, there is a problem of exces-
sive degradation of the LDLR by an overactive protein 
called PCSK9. Each of these problems may affect one of the 
two genes a person has for these proteins, in which case 
the condition is said to be heterozygous FH (heFH). The 
characteristics of heFH are that the LDL cholesterol is 
>5mmol/L (corresponding to a total of >7.0mmol/L), the 
Achilles tendons often become thick in young adults, and 
heart attacks occur in most affected people before the age 
of 55 years. Occasionally 2 parents with heFH pass only 
their defective genes to their children. Such a child has the 
doubly severe problem of homozygous FH (hoFH). In 
hoFH the cholesterol levels are at least double those of 
heFH and cholesterol can deposit in the Achilles tendons as 
well as in the skin of children. Heart disease often happens 
during the teenage years. The diagnosis of heFH and hoFH 
can be made fairly simply and might be con5 rmed by 
genetic testing. Such testing is available at the research 
laboratory in Cape Town but should be requested through 
the medical practitioner who look after patients with severe 
dyslipidaemia so that the most appropriate tests can be 
done. A few underlying other disorders affecting the kidney 
and thyroid should be considered. Very rare other disorders 
may need to be considered in some unusual cases. 
The 5 rst effective treatment for FH arrived in the 1980s: the 
statins. A recent publication demonstrated the difference in 
health in heFH children who commenced treatment around 
1990 and have now reached adulthood. They reached the 
age without the severe heart disease that their parents had 
so prematurely.(4) Although the statins are safe and only 
rarely cause severe adverse effects, they are often not 
powerful enough to achieve the levels of LDL with the least 
risk in FH. The addition of a drug that arrived in the year 
LASSA aims 
to provide the 
expertise in 
service, teaching 




2000, namely ezetimibe, provides very good additional 
lowering. But a few persons with heFH may still need 
additional treatment. This is expected to arrive soon in 
South Africa: monoclonal antibodies to PCSK9. These 
neutralise PCSK9 and thus sustain the LDLR. HoFH 
responds less well and still poses a challenge to treatment. 
Nevertheless, modern medication has also made a big 
impact on health in this serious condition. 
FH occurs in all populations around the world. South Africa 
is renowned for the high prevalence of FH in several 
immigrant communities. The high prevalence, possibly 1 in 
75 families, was noted in Afrikaners in the 1970s. Sub-
sequently a prevalence of 1 in 100 was noted in Jewish and 
Indian communities. FH was found in several other popu-
lation groups in South Africa but the precise prevalence is 
unknown. Errors in all 3 causal genes have been docu-
mented and were published last year(5) along with an 
editorial indicating the problems of treating FH.(6) There 
is already experience with the newest agents in South 
Africa(7) but the approval of these PCSK9 neutralisers has 
been slow. 
Recognition of FH is vital because early and proper control 
of the LDL concentration and other risk factors can ensure 
good health that was rare in previous generations with FH. 
There are about 250 000 persons with FH in South Africa. 
The Heart and Stroke Foundation of South Africa is thus 
an appropriate organisation to promote public awareness 
of this condition as well as its successful treatment. The FH 
Foundation in the USA has not only educated the public 
but also attracted the support for early diagnosis and 
treatment in medical insurance companies.
The year 2020 saw drastic measures being taken to limit 
the expected premature deaths from COVID-19. Hopefully, 
later this year and certainly in 2021, LASSA will ensure that 
FH is identi5 ed and treated so that about 200 000 
premature deaths can be delayed. South Africa, with its 
founder effects and large backlog in identifying FH ought to 
join the “global call to action” for FH. LASSA looks forward 
to joining forces with SAHA, the Department of Health, 
Medical Schemes, the Heart and Stroke Foundation, and 
the public in the interest of FH.
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THE SOUTH AFRICAN HEART ASSOCIATION
RESEARCH SCHOLARSHIP
This scholarship is available to full and associate members of the SA Heart® Association living in South Africa. 
It is primarily intended to assist colleagues involved in much-needed research to enhance their research 
programmes.
REQUIREMENTS
 Applicants need to be fully paid up members/associate members in good standing for at least one year.
  Applications must include:
The applicant’s abbreviated CV
A breakdown of the anticipated expenses
Ethics approval
Full details of the research
The completed application form - please request a fillable MS Word document from erika@saheart.org
Contact details of Head of Department or supervisor/mentor
RECOMMENDATIONS
   Preference will be given to early and mid-career applicants (<5 years post-qualification as specialist and/or 
<5 years post-PhD qualification).
CONDITIONS
   Applicants may only submit 1 application every second year. Preference is given to those who have not had 
previous scholarships awarded.
   Awards are granted for one specific research project. Should that specific project be cancelled or the full 
amount allocated not be utilised for any reason, then the funds must revert to SA Heart®.
APPLICATIONS MUST BE EMAILED TO:
erika@saheart.org
THE SELECTION PANEL WILL REVIEW APPLICATIONS ANNUALLY AND THE CLOSING 
DATE IS 30 SEPTEMBER 2020.
One scholarship to a maximum amount of R65 000 will be awarded annually.
SA Heart® commits to inclusive excellence by advancing equity and diversity.
We particularly encourage applications from members of historically under 




fter a good and optimistic start to the year for 
most of us the world, as we know it, came to a 
grinding halt with the COVID-19 pandemic. 
Academic meetings were cancelled, people were pre-
vented from going to work and patients were prevented 
from coming to hospital. I expected to have very little 
feedback to give but, in true South African fashion, people 
found new and innovative ways to continue providing ser-
vices, and it is with more than a little pride in my colleagues 
that I present this report.
Educational initiatives continue to be a cornerstone activity 
for the Society. 
Calendars are 5 lled with webinars that have become the 
new normal for education events and meetings, and the 
unintended consequence of “webinar fatigue” is dif5 cult to 
avoid. SASCI is, however, focused on providing continuous 
education to the cardiology community though interesting 
and worthwhile topics. This format allows for extended 
reach of audiences and expert faculty internationally.  
The highlights of our educational initiatives since 
the last SA Heart® Newsletter is: 
SASCI INTERNATIONAL WEBINAR: 
COVID-19 AND THE HEART
SASCI hosted, together with the Stellenbosch University 
(Tygerberg Hospital), an International Webinar on 
COVID-19 and the Heart, on 30 April 2020 via Zoom. 
Close to 300 attendees from 23 African countries (including 
RSA, Ghana, Morocco, Namibia, Mauritius, Zimbabwe, 
Kenya, Algeria, Tanzania, Zambia, Congo, Cameroon, 
Ethiopia, Gabon, Uganda, Cameroon, Egypt, Benin, Angola, 
Niger, Cabo Verde, Sudan, Botswana), as well as Singapore, 
Russia, Ireland, Romania, Belgium and the USA participated 
in this event. This truly re) ects the tremendous reach virtual 
events allow us in delegate attendance and faculty. 
A local perspective on the Epidemiology and Projected 
Course of Disease were provided by Prof René English and 
Prof Heike Geduld (Stellenbosch University). International 
faculty included Dr Eric Eeckhout (Switzerland), Prof 
Gregory Barsness (USA), Dr Paul Ong (Singapore) and 
Prof Chris White (USA), who provided their insight into 
how COVID-19 affected interventional cardiology practice 
around the world. Dr Karim Hassan presented on 
“COVID-19 and Myocarditis” with Dr Hellmuth Weich 
elaborated on “Heart drugs for the COVID Patients and 
COVID drugs for Heart Patients”. 
We are incredibly pleased with the attendance and positive 
impact of this webinar and look forward to continuing 
Educational Initiatives via Webinars during the lockdown 
period. 
SASCI AND ISCAP ETHICS WEBINAR
On 11 June 2020, SASCI hosted an Ethics webinar on the 
controversial and thought-provoking topic of resuscitation 
of COVID-19 patients, and the risk to the healthcare 
practitioner, where Prof Henry Lerm, Chairperson-Legal of 
the South African Medico Legal Association, addressed 
the SASCI and ISCAP audience. Prof Lerm highlighted the 
fact that, even though we do not have all the answers now, 
South African Healthcare Practitioner’s need to develop an 
advanced care/risk plan for dealing with pandemics in future. 
Thank you to Dr Sajidah Khan for moderating this webinar 
and to Vertice Medtech for their unconditional educational 
grant and support. This webinar had a tremendous turnout 
of 350 delegates. 
SASCI, CASSA AND PAEDIATRIC 
SOCIETY WEBINAR
The SASCI collaborative Webinar with the Cardiac 
Arrhythmia Society of Southern Africa and the Paediatric 
Society of South Africa was held on 22 July. We had the 
privilege to host Dr Kim Rajappan, a consultant cardiologist 
and electrophysiologist at the John Radcliff Hospital in 
Exford, England, who spoke on approaching the COVID-19 
peak and what to expect in your arrhythmia patients. 
Prof Lindy Mitchell, a paediatric cardiologist at Steve Biko 
Academic Hospital and secretary of the Paediatric Society 
of South Africa, spoke on the tragic impact and effects of 
COVID-19 due to the delayed treatment of children with 
congenital heart disease. 
Thank you to Prof Ashley Chin, President of CASSA, for 
moderating on the call and for Vertice Medtech for their 
continued support. This meeting was well attended by over 
230 delegates. 
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SASCI - SOLUTION FOR CALCIUM – 
WEBINAR
SASCI Vertice Webinar on Solutions for Calcium was 
held on 28 July. During this webinar we were privileged to 
hear from international and local cardiologists on their 
experiences, and varied approaches to dealing with calci5 ed 
arteries. Prof Anthony Gershlick, a cardiologist at Leicester’s 
Hospitals UK, who was a visiting expert to South Africa 
in 2019, presented alongside Dr Pieter Van Wyk and 
Dr Farouk Mamdoo, with Dr Dave Kettles as moderator. 
We had a great turnout of 240 delegates. Thank you to 
Vertice Medtech for sponsoring these webinars.
If you have missed any of these webinars, please visit the 
SASCI Website to listen to the recordings available (allow 
about a 10-day delay).
SASCI COLLABORATIVE WEBINARS 
Renal Denervation Webinar 
A SASCI collaborative Webinar, with Medtronic and 
PASCAR, on Renal Denervation. The international faculty 
included Dr Justin Davies (Cardiologist at the Imperial 
College London, UK) and Dr Jose Antonio Donaire 
(Nephrologist at the European University of Madrid, Spain). 
Dr Mohamed Kurdi (Interventional Cardiologist & Presi-
dent of the Saudi Cardiac Interventional Society in KSA), 
was the moderator for the webinar with Dr Iftikhar 
Ebrahim (Cardiologist at Netcare Unitas Hospital, Pretoria, 
South Africa) representing South Africa as part of the panel. 
This two-part webinar took place on 28 and 29 May 2020, 
with great attendance from across Africa, Europe, UK, 
Middle East, and Asia. 
Pan-African Association of Structural and 
Coronary Intervention Webinar
Pan-African Association of Structural and Coronary Inter-
vention (PASCI), an af5 liated group of PASCAR, hosted a 
Webinar on “How I moved my practice to complex 
intervention”, with Prof Farrel Hellig (South Africa) as key 
faculty, and Dr Mohamed Jeilan (Kenya) and Dave Kettles 
(South Africa) as moderators. The panel included Drs 
Emmy Okello (Uganda), Awad Mohamed (Sudan), Habib 
Gamra (Tunisia) and Ahmed El Guindy (Egypt). Following 
an insightful lecture from Prof Hellig, questions from the 
delegates led to excellent discussions. 
This Pan-African Webinar hosted more than 110 delegates 
from 20 African countries, as well as from as far a5 eld as 
Europe, UK, and the USA. This webinar was made possible 
by unconditional support from Boston Scienti5 c and 
Medtronic. 
SASCI Annual Fellows Workshop 2020
With the current COVID-19 pandemic and government 
regulations, the Fellows Workshop Organising Committee 
had to move this longstanding educational initiative to 
later in 2020 (14 and 15 November), and we plan for a 
hybrid meeting offering both face-to-face attendance, as 
well as joining remotely from different centres in South 
Africa (and even other African countries) through a webinar 
offering. A bene5 t is that virtual presentations will also 
expand our faculty reach to include international and other 
African countries. The academic content will be developed 
by the SASCI Executive under Convenorship of Drs Jean 
Vorster, Graham Cassel and Hellmuth Weich, in collabora-
tion with the Society for Cardiovascular Angiography and 
Interventions (SCAI is the SASCI equivalent in the USA). 
SASCI is also planning a monthly Fellows Webinar Series, 
culminating in the Annual Fellows Workshop, to ensure 
continuous education and engagement with our Fellows 
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ISCAP (INTERVENTIONAL SOCIETY 
OF CATH LAB ALLIED PROFESSIONALS) 
UPDATE 
ISCAP Unit Leaders Virtual Meeting
On 30 May, ISCAP hosted a Cath Lab Unit Managers and 
Leadership Meeting, with cath labs from across South Africa 
represented by more than 30 Unit Managers and ISCAP 
Exco Members. This meeting was focused on the challenges 
each lab faces during the COVID-19 Pandemic, of which 
PPE, redeployment of staff, slates, ethics protocol and 
emotional well-being and support staff were mentioned 
and discussed. ISCAP hopes to build on these relations in 
future, to ensure the support of Unit Managers and the 
Cath Lab teams. 
ISCAP Catheterisation Electronic Manual
Thank you to all the Cath Labs that have embraced the 
online ISCAP Manual and continue to complete the online 
CPD Questionnaires. Each of these delegates receives a 
CPD Certi5 cate for passing the questionnaire (70% Pass 
rate). Allieds who completed all 4 CPD Questionnaires 
receive 12 CPD points (3 CEU’s per module and question-
naire completed).
Please do keep an eye out for communication on 
our UPCOMING ISCAP Webinars with Riverdene 
(August / September) and Medtronic later in 2020.
SASCI PPC, LEGAL AND REGULATORY 
UPDATE
A number of health-related issues, that SASCI felt was 
relevant to our members, were due to be presented to 
parliament or Government Departments. Therefore, with 
input from legal experts, we drew up and submitted formal 
comments for consideration: 
NHI Bill
The objective of the NHI Bill is to provide universal access 
to quality health care for all South Africans, as enshrined in 
the Constitution. The Bill is currently before Parliament. 
However, the COVID-19 pandemic has had an impact on 
the expected timelines set out for the parliamentary 
processes on the Bill. Parliament took a decision (sometime 
in April) to suspend the programme of the National 
Assembly and the National Council of Provinces in the 
interests of social distancing. Though the national legislature 
seems to have found a continuity plan, there are expected 
delays in the enactment of this Bill. However, it cannot go 
without saying that South Africa’s health system has been in 
the spotlight, but the focus has intensi5 ed and will continue 
to do so as the country 5 ghts the COVID-19 pandemic. 
SASCI submitted comments on the NHI Bill and continues 
to monitor the legislative environment for further develop-
ments. 
Draft Public Procurement Bill
It seems that, the Draft Public Procurement Bill of 19 
February 2020 (Bill) is National Treasury’s response to the 
obligations set in section 217 of the Constitution by 
regulating public procurement. 
By the nature of the activities of SASCI members, in par-
ticular, many procedures are technical in nature and require 
the utilisation of a large variety of technical equipment and 
devices, including various components of equipment for 
vascular interventions, structural heart interventions, various 
pacemaker components, etc. These usually have highly 
technical speci5 cations and SASCI was anxious that pro-
curement of these items is made under the guidance of 
experts in the 5 eld, hence the commentary submitted by 
SASCI to the National Treasury on 30 June 2020.
This Bill is meant to consolidate all public procurement 
legislation and to streamline the legal framework in which 
the government can procure goods, services, and infra-
structure. Furthermore, the Bill purports to address 
seemingly contradictory legislation and to address the justi-
ciability of various instruments published by the National 
Treasury. As it appears, the Bill sets out to provide practical 
guidelines for the implementation of procurement rules.
National Multi-sectoral Strategic Plan for the prevention 
and control Non-communicable Diseases, 2021 - 2026
Non-Communicable Diseases (NCDs), pose one of the 
biggest threats to health and development globally, parti-
cularly in low- and middle-income countries. The National 
Strategic Plan seeks to direct the actions that will be 
undertaken between 2020 and 2025 across sectors to 
redress and to reverse the growing threat posed by 
NCDs. The overarching objective of this Plan is to prepare 
the country for reaching the Sustainable Development 
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Goals related to NCDs (to reduce, by one-third, premature 
mortality from non- communicable diseases (NCDs) 
through prevention and treatment, and promote mental 
health and well-being by 2030 (Goal 3.4).
SASCI is of the view that there are ) aws in the National 
Multi-Sectoral Strategic Plan for the Prevention and Control 
of Non-Communicable Diseases 2021-2026, which need 
to be addressed. Consequently, SASCI has submitted 
comments to the National Department of Health on 
31 July 2020.
We thank Ebbie Iheanyi (lawyer at EKA) for her diligent 
and professional legal services, as well as Dr Tom Mabin 
who continues to contribute substantially from the 
practitioner perspective.
SASCI INTERACTION WITH FUNDERS
Discovery Health CAD Programme for 2020
Discovery Health Coronary Artery Disease (CAD) Care 
Governance Initiative negotiations are underway with 
SASCI. There is a review of a draft proposal underway that 
is aimed at regulating the possible relationship between the 
individual practices which opt to participate in the pro-
gramme and Discovery Health. There have been lessons 
learnt from the previous CAD agreements with Discovery 
Health, which necessitated a review of the contract. There 
have, furthermore, been learnings from the Discovery 
Health forensic audits on individual practices which had to 
be factored into the contract. SASCI will continue to work 
towards ensuring that our members interest is profes-
sionally represented to the ultimate bene5 t of your patients.
Medihelp TAVI case
SASCI’s complaint to the Council for Medical Schemes 
(CMS), in terms of section 47 of the Medical Schemes Act, 
was ruled in SASCI’s favour against Medihelp. Medihelp 
appealed the decision of the Registrar of the CMS and 
SASCI is seeking a set-down date at the Appeals Com-
mittee to have the matter heard. SASCI is cognisant of the 
delays which have plagued the CMS of late, and which have 
been exacerbated by the COVID-19 pandemic. Notwith-
standing, SASCI will continue to engage with the CMS to 
bring 5 nality to the matter.
Medihelp vascular codes
SASCI was extremely concerned about the non-funding of 
vascular codes by Medihelp, which are part of the scope of 
the profession of cardiology, and which activities cardi-
ologists can, under Rule 21 of the HPCSA ethical rules, 
perform. The blanket ban imposed on payment for these 
valid and legislated procedures was unique to Medihelp and 
SASCI viewed this stance as unjusti5 ed and unacceptable. 
SASCI continued to engage Medihelp to resolve such 
matters and it appears that, after 2-year impasse, this seems 
to have been resolved. Members are requested to revert to 
the SASCI of5 ce if theses codes are rejected. 
Whether a specialist physician can perform interventions 
in the K eld of cardiology
Medscheme was disputing payment of certain claims relating 
to interventional cardiology procedures on the basis that 
the healthcare professional was not registered as a Cardi-
ology sub-specialist, but rather as a general Physician (018). 
Cardiology seems to only have been recognised as a sub-
specialty by the HPCSA in the mid-1980s and, up to that 
time, all that was required to practise cardiology was 2 
years cardiology training in a recognised training facility after 
registering as a physician. Such a generation of practitioners 
were recognised as cardiologists but were not registered as 
such by the HPCSA. SASCI’s view was that, should the 
General Physician be trained and experienced in rendering 
the speci5 c services, it would be irrational and unreasonable 
to prevent the healthcare professional from undertaking 
such services, in particular where patients require access to 
such life-saving interventions. Medscheme was informed 
therefore that they cannot prohibit a professional service 
from being performed however may question the pro-
fessional codes being used and the fees which the pro-
fessional charges. 
All SASCI submissions can be accessed at http://
www.sasci.co.za/content/page/sasci-guidelines
SASCI CODING PROJECTS OVERVIEW
There are two major coding projects being conducted in 
cardiology under the auspices of SASCI PPC, with Karen 
van der Westhuizen (coding expert) and Dr Tom Mabin 
(practitioner expert) as project leads:
 ■  The Cardiology Coding Handbook (update 2020) 
 ■  The Cardiology MDCM (Medical Doctor’s Coding 
Manual) Coding update with CCSA2018 crosswalk 
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THE CARDIOLOGY CODING HANDBOOK
The SASCI Coding Handbook was created in 2014 by 
Dr JP Theron, et al. The purpose of the handbook is to 
create uniformity in coding standard procedures. This also 
creates a platform for communication where available 
codes are not suf5 cient.
The SASCI Coding Handbook was extensively reviewed in 
the that past 6 months with assistance from various private 
sector practitioners and coding experts. New coding 
scenarios were added to the handbook and the master 
draft document has been sent for 5 nal review. We expect 
to issue the updated version to be available before the end 
of 2020.
The review of the document entails, but is not be limited to, 
the following:
 ■  The handbook layout to be more user-friendly 
 ■  The coded scenarios should re) ect current coding 
practice 
 ■  Possible clinical procedure shortfalls should be identi5 ed 
and address by consensus opinion 
It is important to remember that the Coding Handbook is 
a living document. Scenarios and guidelines will be added 
as the need arises. Feedback from practitioners on the 
document is required to ensure clinical completeness and 
validity. 
Once the Executive Committee has signed-off, and the 
legal opinion updated, the SASCI Coding Handbook 2020 
will be ready for distribution.
THE CARDIOLOGY MDCM CODING 
UPDATE
A completed MDCM (Medical Doctor’s Coding Manual) 
review was sanctioned by SASCI in February 2019. CCSA 
2018 is used as the benchmark for the Cardiology MDCM 
update. CCSA is the industry accepted benchmark to use 
when a MDCM code update is requested. The MDCM 
updates are approved and published by SAMA (South 
African Medical Association) after submission and extensive 
consultation. This will be the 5 rst MDCM update in 
cardiology since 2006 and is crucial to substantially move 
cardiology coding forward. 
The Cardiovascular System has now been cross walked to 
CCSA2018, except for the Open-Heart Surgery and 
Peripheral vascular system. SASCI is awaiting con5 rmation 
from the Paediatric cardiologists to update their section. 
New MDCM codes are proposed, based on CCSA2018 for 
procedures, as well as on new technology, while some 
MDCM descriptions will change based on CCSA2018, 
some will be deleted, and some will remain the same.
Meetings were held with Discovery and Medscheme to 
allocate resources for modelling and cost-analysis of the 
codes. Both meetings were very productive, and the funders 
expressed their gratitude for including them in the update 
process. Active engagement with the funders will continue 
through out 2020. 
SAMA staff resources are unfortunately limited as the 
SAMA principal has been on sick leave since the beginning 
of the lockdown. SAMA indicated that normalisation is 
expected by August, which will lead to scheduling of the 
next SAMA review meeting. 
The crosswalk is currently being analysed using the CCI-
edits in combination with MDCM (CCI is the Correct 
Coding Initiative published in America to prevent unbundling 
or over coding). This CCI analysis will be utilised by the 









funders to calculate the costing of the new crosswalk. This 
will indicate if the crosswalk is cost-neural to both funders 
and practitioners, or if the cost implication could be detri-
mental to either. 
Please do engage with Karen van der 
Westhuizen (via the SASCI ofP ce if needed).
All of the above represents a signi5 cant investment of time 
and effort from many people (including admin staff, aca-
demic input, sponsors and legal experts) and I would like 
to end by thanking every individual involved. Without you 




STEMI SA UPDATE JULY 2020
The aim of STEMI SA is to educate, improve networks and 
facilitate early reperfusion therapy of patients with ST 
elevation myocardial infarction in South Africa. This initia-
tive is a national programme, under SASCI, with clear goals 
and timelines.
We have a well-balanced group from both the public and 
private sectors, who are young and more experienced, as 
well as incorporating those individuals who have been 
instrumental in setting up STEMI SA. We would like to 
thank Dr Adriaan Snyders for his leadership and we are 
grateful that we will have his continued support, as he has 
taken on the role of Sent Save A Life (SSL) liaison for our 
community.
It is now time for us to put words into action and establish 
a well-coordinated National Database, which is well-
validated and that can be used for further research and 
collaboration, with the ultimate aim of improving the care 
of patients with STEMI. The plan is to implement a National 
STEMI Registry towards the end of 2020.
We intend to improve the Systems-of-Care through 2 main 
arms - namely research and education. The research should 
ultimately lead to publication, inform our educational initia-
tives, and improve systems of care.
RESEARCH
 ■  The STEMI Datasheet has been 5 nalised.
 ■  It was decided that the STEMI India Database platform 
will be best suited to South Africa, it is a pre-existing 
online platform, minimal costs need to be incurred and 
we align with the vastly experience of Dr Thomas 
Alexander.
 ■  A Publications Policy Task Team was formed to estab-
lish protocols, ethics, consent form and a publication 
policy.
PUBLICATIONS IN PRESS
 ■  Interventional cardiology in the COVID-19 pandemic.
 ■  Decline in acute coronary syndrome hospitalisation 
rates during COVID-19 lockdown in private hospitals in 
South Africa.
 ■  Stent Save a Life! International survey on the practice of 
primary angioplasty during the COVID-19 pandemic.
EDUCATION
 ■  We plan to update the online SASCI website with user-
friendly slides on the investigation and management of 
STEMI.
 ■  Regional education workshops will be planned post-
COVD, with virtual education being made available as 
and when appropriate during the pandemic.
We would welcome involvement from 
healthcare providers and industry. 
If anyone would like to participate, kindly 
liaise with George Nel at the SASCI ofP ce 
(george@medsoc.co.za). 






accepted by the relevant congress organising committee, 
the applicant will forfeit his or her sponsorship towards 
the congress. (Application can however be made well in 
advance of the relevant congress but will only be awarded 
on acceptance of the abstract.) A written report on the 
relevant congress attended will need to be submitted by 
the successful applicant within 6 weeks of attending the 
congress. The congress report will be published in the 
South African Heart Association Newsletter.
Applications should be sent to Dr Alfonso Pecoraro, 
President of the Western Cape branch of the South 
African Heart Association, Division of Cardiology, Tyger-
berg Hospital, Francie van Zijl Drive, Tygerberg 7505; or 
alternatively email: pecoraro@sun.ac.za.
Previous recipients of this prestigious award include 
Sandrine Lecour, Roisin Kelle, Liesl Zühlke and Prof Hans 
Strijdom. 
Applications close on 31 January 2021.
LOUIS VOGELPOEL TRAVELLING SCHOLARSHIP
A gifted and 
enthusiastic 
teacher, he was 
instrumental in 




pplications are invited for the annual Louis 
Vogelpoel Travelling Scholarship for 2020. 
An amount of up to R20 000 towards the 
travel and accommodation costs of a local or interna-
tional congress will be offered annually by the Western 
Cape branch of the South African Heart Association in 
memory of one of South Africa’s outstanding cardiologists, 
Dr Louis Vogelpoel. 
Louis Vogelpoel was a pioneer of cardiology in South 
Africa who died in April 2005. He was one of the 
founding members of the Cardiac Clinic at Groote Schuur 
Hospital and the University of Cape Town. He had an 
exceptional career of more than 5 decades as a dis-
tinguished general physician, cardiologist and horticultural 
scientist. Dr Vogelpoel’s commitment to patient-care, 
teaching and personal education is remembered by his 
many students, colleagues and patients. Medical students, 
house of5 cers, registrars and consultants bene5 ted from 
exposure to his unique blend of clinical expertise, extensive 
knowledge, enthusiasm and gracious style. 
A gifted and enthusiastic teacher, he was instrumental in 
the training of generations of undergraduates by regular 
bedside tutorials. He served as an outstanding role model 
for postgraduates and many who have achieved pro-
minence nationally and internationally acknowledged his 
contribution to the development of their careers. 
All applications for the scholarship will be reviewed by the 
executive committee of the Western Cape branch of the 
South African Heart Association. Preference will be given 
to practitioners or researchers in the 5 eld of cardiovascular 
medicine who are members of the South African Heart 
Association and are resident in the Western Cape.
Applications should include: (1) A brief synopsis of the 
work the applicant wishes to present at the congress; and 
(2) A brief letter of what the applicant hopes to gain by 
attending the relevant congress. The applicant should sub-
mit an abstract for presentation at the relevant national or 
international meeting. Should such an abstract not be 
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TRAVEL SCHOLARSHIPS OF THE 
SOUTH AFRICAN HEART ASSOCIATION
Applications for the SA Heart® Travel Scholarship for the third term in 2020 are invited to reach the SA Heart® 
Office by 30 September 2020.
The scholarship is for the value of up to R25 000.00 for international meetings and R10 000.00 for local meetings.
This scholarship is available to all members residing in South Africa. It is primarily intended to assist junior 
colleagues to ensure continued participation in local or international scientific meetings or workshops.
REQUIREMENTS
 Applicants must be fully paid-up members for at least 1 year.
RECOMMENDATIONS
  Early and mid-career applicants (<5 years post-qualification as specialist and/or <5 years post-PhD qualification).
  Acceptance of an abstract/poster presentation at the scientific meeting to be attended.
CONDITIONS
  Awards will not be made for conferences or workshops retrospective to the application submission deadline. 
If the conference is taking place within six (6) weeks following the submission deadline, please indicate this in 
the appropriate place on the application form.
  It is not a requirement for the abstract to be accepted by the conference travel application closing date. 
Should the acceptance of the paper, including proof of registration not be available at the time of submission 
of the application, then a provisional award may be made pending receipt of the acceptance of the paper.
  Please ensure that applications are made as well in advance as possible (preferably at least 6 months prior 
to the conference date).
  Applicants may only submit 1 application every second year. The scholarship is for the value of up to 
R25 000.00 for international meetings and R10 000.00 for local meetings.
  Awards are only made in the event that a paper or a poster is being presented or in the event of a workshop 
attendance, if the reviewers deem the workshop attendance to be of high impact and consequently of benefit 
to the SA Heart® community.
  The applicant must ensure that the application is fully completed including the requirements as detailed in the 
checklist section. Applicants are asked to be concise and to only include applicable and relevant information.
  Awards are granted for 1 specific conference. Should that specific conference be cancelled or the full amount 
allocated not utilised for any reason, then the funds must revert to SA Heart®; and
  A written report on the relevant congress attended will need to be submitted by the successful applicant 
within 6 weeks of attending the congress. The congress report will be published in the South African Heart 
Association Newsletter.
SUBMISSION REQUIREMENTS





The SA Heart® AGM 2020 will take place online. 
Due to the Pandemic many programmes and calendars have 
had to change. The date for the AGM, will be sent out 
electronically to all members of SA Heart® once it is P nalised.
All members are invited to attend.
Ordinary members of SA Heart® are called to partake actively 
in the nomination and election process for ofP ce bearers.
SA HEART® ANNUAL GENERAL MEETING
